# 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial

> **NCT06638125** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 89 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DEVICE:** 3-Dimensional VR Modelling (Elucis) with Intravascular Indocyanine Green Fluorescence Mapping
- **DEVICE:** 3-Dimensional Modelling (Synapse 3D) with Intravascular Indocyanine Green Fluorescence Mapping

## Key facts

- **NCT ID:** NCT06638125
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 89 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06638125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06638125, "3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06638125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*